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Abstract
Malaria is a parasitic disease that is a major health problem in many tropical
regions. The most characteristic symptom of malaria is fever. The fraction of fevers
that are attributable to malaria, the malaria attributable fever fraction (MAFF), is an
important public health measure for assessing the effect of malaria control programs
and other purposes. Estimating the MAFF is not straightforward because there is
no gold standard diagnosis of a malaria attributable fever; an individual can have
malaria parasites in her blood and a fever, but the individual may have developed
partial immunity that allows her to tolerate the parasites and the fever is being caused
by another infection. We define the MAFF using the potential outcome framework
for causal inference and show what assumptions underlie current estimation methods.
Current estimation methods rely on an assumption that the parasite density is cor-
rectly measured. However, this assumption does not generally hold because (i) fever
kills some parasites and (ii) the measurement of parasite density has measurement
error. In the presence of these problems, we show current estimation methods do not
perform well. We propose a novel maximum likelihood estimation method based on
exponential family g-modeling. Under the assumption that the measurement error
mechanism and the magnitude of the fever killing effect are known, we show that our
proposed method provides approximately unbiased estimates of the MAFF in sim-
ulation studies. A sensitivity analysis can be used to assess the impact of different
magnitudes of fever killing and different measurement error mechanisms. We apply
our proposed method to estimate the MAFF in Kilombero, Tanzania.
Keywords: Bayes deconvolution problem; Causal inference; Exponential family G-modeling;
Two-component mixture model.
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1 INTRODUCTION
Malaria is a mosquito-borne infectious disease caused by a parasite. In many tropical re-
gions, malaria is a giant-killer of children, imposes financial hardship on poor households,
and holds back economic growth and improvements in living standards (World Health
Organization, 2011). The most characteristic clinical feature of malaria is fever (Warrell
1993). The malaria attributable fever fraction (MAFF) for a group of people is the pro-
portion of fevers in the group of people that are attributable to (caused by) malaria. We
will consider the MAFF for children in sub-Saharan Africa, the population hit hardest by
malaria (World Health Organization, 2011). The MAFF is an important public health
quantity for several reasons that include
• The MAFF provides information about the public health burden from malaria and
how much resources should be devoted to combatting malaria compared to other
diseases (Mabunda et al. 2009).
• The MAFF is an essential input to the prevalence of malaria attributable fevers
(PMAF); the PMAF equals MAFF × prevalence of fevers. Changes in the PMAF
over time provide information about the effects of public health programs that combat
malaria (Koram & Molyneux 2007).
• For planning the sample size for a clinical trial of an intervention against malaria,
the MAFF is an essential input (Halloran et al. 1999, Smith 2007). For example,
suppose we are planning a trial of duration one year and want to have 80% power
for an intervention that halves malaria attributable fever but has no effect on other
sources of fever, and in the population of interest, the average child suffers from
10 fevers per year. The needed sample size depends on the MAFF and is about
n = (800, 1325, 2500) in this example if the MAFF is (0.5, 0.4, 0.3) respectively. The
details of the sample size calculation are in the Supplementary Materials.
• For clinicians treating a child suffering from fever and needing to decide how to
prioritize providing antimalarial treatment vs. treatments for other possible sources of
the fever, knowing the MAFF conditional on the child’s symptoms (e.g., the intensity
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of the fever and the child’s parasite density) is a valuable input (Koram & Molyneux
2007). In particular, letting ‘MAFF | Symptoms’ denote the MAFF conditional on
the child’s symptoms, a doctor would want to treat a patient with an anti-malarial
if (Expected gain in utility from treating child at time t with an anti-malarial if she
has a malaria attributable fever vs. not treating)×(MAFF | Symptoms) > (Expected
loss in utility from treating child at time t with an anti-malarial if she has a fever
that is not malaria attributable fever vs. not treating) × [1-(MAFF | Symptoms)].
The MAFF could be estimated from a survey by a usual ratio estimator if it was
easy to determine whether or not a fever was attributable to malaria parasites. However,
fevers caused by malaria parasites often cannot be distinguished on the basis of clinical
features from fevers caused by other common childhood infections such as the common cold,
pneumonia, influenza, viral hepatitis or typhoid fever (Hommel 2002, Koram & Molyneux
2007). One aid to deciding whether a fever is caused by malaria parasites or some other
infection is to measure the density of malaria parasites in the child’s blood. However, in
areas where malaria is highly endemic, children can develop partial immunity to the toxic
effects of the parasites and can tolerate high parasite densities without developing fever
(Marsh 2002, Boutlis et al. 2006). Consequently, even if a child has a fever and has a high
parasite density, the fever might still be caused by another infection. In summary, it cannot
be determined with certainty whether a given child’s fever is malaria attributable, making
estimating the MAFF challenging.
In this paper, we make two contributions to estimating the MAFF. First, we provide an
analysis of the assumptions needed for existing estimators of the MAFF to be consistent and
show that these assumptions are not plausible. In previous work on estimating the MAFF,
estimators have been proposed without clearly defining the estimand. We use the potential
outcomes framework to clearly define the estimand and make clear the causal assumptions
on which the consistency of these previous estimators rest. These assumptions include that
non-malaria attributable fevers do not kill parasites and that there is no measurement error
of a certain type in measuring parasite density. We discuss evidence that these assumptions
are not plausible in most settings, and show that existing MAFF estimation methods are
biased under plausible violations of the assumptions.
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The second major contribution of our paper is that we develop a consistent estimator
of the MAFF that allows for parasites being killed by fever and measurement error in
parasite density. Our novel estimation method extends the g-modeling method for solving
deconvolution problems (Efron 2016) to the setting of malaria survey data, accounting
for parasites being killed by fever and measurement error. Specifically, survey data on
malaria can be divided into two groups, the children with fever (the febrile group) and
the children without fever (the afebrile group). The group with fever is a mixture of
two components: children with a fever that is malaria attributable and children with a
fever that is not malaria attributable. The group without fever can be used as a training
sample that provides information about the distribution of parasite densities of the latter
mixture component. The main idea of our method is to recover the distributions of the
parasite densities of the mixture components before fever killing and measurement error
by assuming that the mixture components are in flexible exponential families and solving
the deconvolution problem. Using simulation studies, we show that our proposed method
produces approximately unbiased estimates of the MAFF when the magnitude of fever
killing and the measurement error mechanism are correctly specified. We apply our method
to make inferences about the MAFF for a study area in Kilombero, Tanzania.
The rest of this article is organized as follows. In Section 2, we define the MAFF
and state critical assumptions in the potential outcome framework. We also reveal the
relationship between the potential outcome framework MAFF and the probability limits
of the conventionally used estimators of the MAFF based on observable quantities under
the assumptions. Section 3 describes possible violations of the assumptions that there
is no fever killing and no measurement error. Also, the impact of a violation of these
assumptions on current estimation methods is investigated. In Section 4, we develop our
new estimation method, the maximum likelihood estimation method using the g-modeling
approach. Section 5 shows the performance of our proposed method with simulation studies
and Section 6 shows the application to the malaria data in Tanzania with a sensitivity
analysis. Section 7 includes summary and discussion.
4
2 MALARIA ATTRIBUTABLE FEVER FRACTION
(MAFF)
2.1 Potential Outcome Definition
To define a fever as being caused by (i.e., attributable to) malaria parasites, we use the
Neyman-Rubin potential outcomes framework for causal inference (Neyman 1923, Rubin
1974). For each child i and each possible parasite density level d, the potential outcome
Y
(d,z)
i is 1 or 0 according to whether or not the child would have fever if an intervention set
the child’s parasite density level to d and the amount of non-malarial infections to z. (the
intervention does not need to be specified but need to satisfy Assumption 1 which we will
discuss below). Each child has many potential outcomes, but we observe only one potential
outcome, Y obsi ≡ Y
(Di,Zi)
i , where Di is the child’s actual parasite density (we are only able to
measure Di with some error; see Section 3) and Zi is the amount of non-malarial infections
that the child has (we cannot directly observe Zi, but assume that Zi = 0 means no non-
malarial infection and higher levels of Zi mean more non-malarial infections). In addition
to the actually observed outcome Y obsi , we also consider the potential outcome under an
intervention that eliminates malaria parasites from the child’s body, Y nmii ≡ Y
(0,Zi)
i ; the
‘nmi’ stands for whether the child would have a fever if the malaria parasites were eliminated
and the only possible source of fever were a non-malarial infection (nmi). Let T nmii be the
threshold of non-malaria infection Z that would be needed to trigger a non-malarial fever
if the malaria parasites were eliminated. If Zi is greater than or equal to T
nmi
i , then we
define the child to have a non-malarial fever (i.e. Y nmii = 1). If Y
nmi
i = 1, then the child
has a fever that is not attributable to malaria because the fever would be present even if
the malaria parasites were eliminated.
Malaria parasites are thought to cause fever by causing the red blood cells they invade to
rupture, releasing an insoluble hemoglobin digestion product, hemozoin, which stimulates
innate immune responses that cause the body’s temperature to rise (Parroche et al. 2007).
A child’s pyrogenic threshold is the minimum malaria parasite density at which these
immune responses will result in a fever if there is no non-malarial infection; the pyrogenic
threshold varies from child to child based on factors such as the child’s acquired immunity
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(through previous exposure to malaria) and natural immunity (e.g., genetic inheritance of
the sickle cell trait) (Rogier et al. 1996, Langhorne et al. 2008, Taylor et al. 2012). Let Tmii
denote child i’s pyrogenic threshold. We denote Y mii ≡ Y
(Di,0) as a variable that indicates
whether the density exceeds the threshold Tmii , i.e., whether the child’s malaria infection
(mi) is strong enough to cause a fever in the absence of any non-malaria infection; Y mii = 1
if Di ≥ T
mi
i and Y
mi
i = 0 otherwise. This definition implies that if Di ≥ T
mi
i , then the child
has a malaria fever (Y mii = 1), thus resulting in Y
obs
i = 1. However, the opposite is not
true. Even if Y obsi = 1, we do not know whether Y
mi
i is 1 or not. It is possible that the fever
is caused only by a non-malaria infection, Y nmii = 1 but Y
mi
i = 0 (meaning Di < T
mi
i ).
Note that it is possible that both Y mii = 1 and Y
nmi
i = 1, meaning that the child has both a
malaria infection that exceeds the child’s pyrogenic threshold and a non-malarial infection
that would cause a fever even if the child’s malaria parasites were eliminated. We assume
for now that the way malaria and non-malaria infections affect a fever is like parallel circuits
so that a fever happens if and only if Y mi = 1 and/or Y nmi = 1, i.e., the observed outcome
Y obsi can be represented by a function of Y
nmi
i and Y
mi
i : Y
obs
i = min{Y
nmi
i + Y
mi
i , 1}. This
is specified as Assumption 2 (iv) below. We will relax this assumption in Section 4.3.
We define a child i who is observed to have a fever as having a malaria attributable
fever if that fever would not have occurred if the child had been given an intervention
that prevented the child from having malaria parasites. In terms of potential outcomes, a
child i has a malaria attributable fever if Y obsi = 1 but Y
nmi
i = 0. Let (Y
mi, Y nmi) be the
random vector from the experiment of choosing a random child and time point from the
study area and study period. The fraction of fevers in the study area and time period that
are attributable to malaria, i.e., the MAFF, is
MAFF = P (Y nmi = 0, Y obs = 1|Y obs = 1). (1)
Because we have defined the MAFF using potential outcomes based on an intervention
that could alter parasite density, the MAFF could depend on the intervention that alters
parasite density, e.g., possible interventions are antimalarial drugs, vaccines and control of
the mosquitoes that carry the malaria parasites. Consider an intervention that satisfies:
Assumption 1 No Side Effects Assumption. The intervention has no effects on fever
beyond removing the parasites from the child.
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Assumption 1 implies that the intervention cannot cause a fever:
P (Y nmi = 1, Y obs = 0) = 0. (2)
Under the no side effects assumption, the MAFF can be interpreted as the proportion of
fevers in the observed world that would be eliminated if malaria were eradicated by the
intervention. We will not specify the intervention under consideration but will assume
that the intervention satisfies Assumption 1. Although it is possible that interventions
currently being studied could have side effects and violate Assumption 1, the MAFF for a
hypothetical intervention that satisfies Assumption 1 provides an estimate of the potential
benefit of an intervention to eliminate malaria which is useful for policymakers (Walter
1976).
The potential outcome framework MAFF (1) is defined based on unobservable variables
Y nmi and Y mi. In order to identify the MAFF from data, assumptions need to be made
about the way these unobserved variables link to observed variables. In the following
section, we discuss identifying assumptions.
2.2 Assumption
To estimate the MAFF, we make the following assumptions:
Assumption 2 The potential outcome Y (d,z) and the pyrogenic thresholds T nmii and T
mi
i
satisfy that
(i) (Monotonicity Assumption)
– if d ≤ d′, then Y (d,z) ≤ Y (d
′,z) for all z.
– if z ≤ z′, then Y (d,z) ≤ Y (d,z
′) for all d.
(ii) the pyrogenic thresholds T nmi and Tmi are strictly greater than zero.
(iii) a fever caused by a non-malaria infection Y nmi is independent of a fever caused by a
malaria infection Y mi, i.e. Y nmi ⊥⊥ Y mi.
(iv) Y obs = min{Y nmi + Y mi, 1}
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Assumption 2 (i), the monotonicity assumption, is biologically plausible because having
more parasites means that more red blood cells are ruptured by the parasites and more
hemozoin is released, meaning that if a child’s hemozoin level was enough to cause a fever
at parasite level d, then a child would surely have a fever at parasite level d′ since the
child’s hemozoin level would be even higher. Similarly, the monotonicity assumption for
non-malaria infections z is plausible. Assumption 2 (ii) is also biologically plausible because
it says that a fever cannot be triggered by malaria parasites if there are no malaria parasites
present. Similarly, it is also plausible for non-malarial infections. Assumption 2 implicitly
defines Y (T
mi,Z) = 1 for the pyrogenic threshold Tmi. If the parasite density reaches the
pyrogenic threshold, then a fever is observed. Furthermore, it follows that Y (d,z) = 1 for
any d > Tmi. We emphasize that this assumption does not imply that Y (d,z) = 0 if d < Tmii ;
the child could have a fever from a non-malarial infection, Y nmi = 1. Assumption 2 (iii)
means that the potential outcome Y nmi is independent of the indicator I(D ≥ Tmi). This
assumption implies that there is no causal pathway between the parasite density D and
Y nmi, and also no causal pathway between the pyrogenic threshold Tmi and Y nmi. This
assumption may be more plausible after controlling for observed covariates and we show
how we control for observed covariates in Section 4.3. Also, the impact of the violation of
the assumption is investigated by conducting a sensitivity analysis. Assumption 2 (iv) is
the assumption discussed in Section 2.1 that the way malaria and non-malaria infections
affect a fever is like parallel circuits. We will develop a sensitivity analysis for violations of
this assumption in Section 4.3.
2.3 Additional Assumptions Needed for Existing Estimators
We will show in this section that the existing estimators of the MAFF are not consistent
under Assumptions 1 and 2 alone, and that an additional, implausible assumption is needed.
Let pf be the parasite prevalence in febrile children and pa be the parasite prevalence in
afebrile children. That is, pf = P (D
obs > 0|Y obs = 1) and pa = P (D
obs > 0|Y obs = 0)
where Dobs is the observed parasite density. One popular estimator is based on the relative
risk (Smith et al. 1994), which is equal to pˆf (Rˆ − 1)/Rˆ where pˆf = Pˆ (D
obs > 0|Y obs = 1)
and Rˆ = Pˆ (Y obs = 1|Dobs > 0)/Pˆ (Y obs = 1|Dobs = 0). This estimator is proposed as
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the population attributable fraction estimator by Greenwood et al. (1987), and discussed
in Smith et al. (1994). The estimator of the MAFF based on relative risk converges in
probability to
plim(M̂AFFRR) = pf(R− 1)/R (3)
where R is the relative risk of fever associated with the exposure of parasites, i.e. R =
P (Y obs = 1|Dobs > 0)/P (Y obs = 1|Dobs = 0). We note that pa, pf and R can be estimated
from the observed data (Y obs, Dobs). The consistency of the estimator M̂AFFRR relies on
the following assumption.
Assumption 3 No Errors Assumption. The parasite density does not change before and
after having a fever caused solely by a non-malaria infection, Y nmi = 1, Y mi = 0, and the
observed parasite density Dobs is measured without error.
In Section 3, we will discuss that the no errors assumption is implausible. Under Assump-
tions 1 - 2 and the no errors assumption, the following proposition reveals that M̂AFFRR
is consistent.
Proposition 1 Under Assumptions 1 - 3, the potential outcome framework MAFF is equal
to the relative risk MAFF. That is, MAFF = plim(M̂AFFRR).
The proof is provided in the Appendix.
Another popular choice of an estimator for the MAFF based on odds ratio is M̂AFFOR =
(pˆf − pˆa)/(1− pˆa) that has the probability limit, plim(M̂AFFOR). This estimator is an
approximated version of the estimator pˆf(Rˆ − 1)/Rˆ because the relative risk R is often
approximated by the odds ratio, pf (1− pa)/pa(1− pf). Then, the probability limit of this
estimator is obtained as
plim(M̂AFFOR) = (pf − pa)/(1− pa). (4)
plim(M̂AFFOR) is approximately equal to plim(M̂AFFRR) when the prevalence of cases
is rare.
Proposition 2 Under Assumptions 1-3, in terms of the potential outcome framework,
plim(M̂AFFOR) is given by
plim(M̂AFFOR) =
P (Y mi = 1)
P (Y obs = 1)
=
plim(M̂AFFRR)
P (Y nmi = 0)
. (5)
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The proof is also provided in the Appendix. According to Proposition 2, under Assump-
tions 2 and 3, M̂AFFOR is an asymptotically biased estimator of the MAFF, and estimates
the proportion of children who have malaria fevers among febrile children P (Y mi = 1|Y obs =
1), not the MAFF.
Proposition 2 implies that plim(M̂AFFOR) is strictly larger than plim(M̂AFFRR) when
the probability of having non-malaria caused fever is positive. Technically, plim(M̂AFFRR)
is represented by multiplication of the probability of not having non-malaria caused fever
P (Y nmi = 0) and plim(M̂AFFOR) as shown by equation (5). If the target estimand of
some methods is plim(M̂AFFOR), the estimate from the method should be adjusted by
multiplying P (Y nmi = 0) in order to acquire the estimate of plim(M̂AFFRR). However,
one difficulty is that P (Y nmi = 0) is not observable. The following proposition shows that
this adjustment can be successfully achieved by estimating P (Y nmi = 0).
Proposition 3 Under Assumption 1-3, the estimator M̂AFFRR can be represented by
the estimator M̂AFFOR and the probability p = ̂P (Y obs = 1). Let λ = M̂AFFRR and
λ∗ = M̂AFFOR. Then, λ is obtained as
λ =
λ∗ − pλ∗
1− pλ∗
. (6)
Proof. From equation (5),
λ = P (Y nmi = 0) · λ∗
=
P (Y mi = 0)P (Y nmi = 0)
P (Y mi = 0)
· λ∗
=
1− P (Y obs = 1)
1 − P (Y mi = 1)
· λ∗
=
1− p
1− pλ∗
· λ∗.
There have been many estimators developed to estimate the MAFF. These estimators
mainly can be classified as belonging to two different approaches through either estimat-
ing plim(M̂AFFRR) or estimating plim(M̂AFFOR). The first approach is to estimate the
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probability of having a fever given a parasite density D, P (Y obs = 1|D), in order to esti-
mate plim(M̂AFFRR). This estimate leads to an estimate of the relative risk R to obtain
an estimator M̂AFFRR. The simplest model is using the logistic regression to estimate the
probability P (Y obs = 1|D) (Smith et al. 1994). A slightly more complicated model that
was preferred by Smith et al. (1994) adds an additional power parameter to the logistic
regression. Also, nonparametric regression models can be considered such as local linear
smoothing (Wang & Small 2012). However, if data are collected from a case-control study
and the prevalence of fever is not known, then P (Y obs = 1|D) cannot be fully estimated,
but pf and pa can be estimated. In this situation, the second approach is to estimate the
probability density functions in both the febrile and afebrile subgroups (i.e. estimate the
densities f(D|Y obs = 1) and f(D|Y obs = 0)) in order to estimate plim(M̂AFFOR). The
febrile subgroup consists of samples from both the non-malaria caused fever population
and the malaria caused fever population. The afebrile subgroup is a sample from the non-
malaria caused fever population in the febrile subgroup. Under the no errors assumption,
the parasite density of the non-malaria caused fever population has the same distribution
as the parasite density of the afebrile subgroup. The afebrile subgroup is used as training
data to deconvolve the mixture in the febrile subgroup. This data structure is sometimes
called a two-component mixture problem. To tackle the two component mixture prob-
lem, semiparametric estimation models using empirical likelihood (Qin & Leung 2005) and
Bayesian estimation (Vounatsou et al. 1998) have been considered. These models provide
a consistent estimate of plim(M̂AFFOR). However, plim(M̂AFFOR) does not equal the
MAFF even under the no errors assumption - see Proposition 2. Therefore, an additional
step is required to adjust the obtained estimator M̂AFFOR using equation (6) to obtain
an estimator that would be consistent under Assumptions 1-3.
The new estimation method we will develop in Section 4 is based on estimating plim(M̂AFFOR)
and then adjusting the estimate by multiplying it by ̂P (Y nmi = 0) to estimate the MAFF.
Using M̂AFFRR is more straightforward than using M̂AFFOR because it does not require
the adjustment. However, the estimator M̂AFFRR can perform poorly when the propor-
tion of afebrile children without parasites is small. The performance of M̂AFFRR depends
on the precision of estimating P (Y obs = 1|D), but the estimation can be noisy in usual
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malaria data. More importantly, the approach that uses the estimator M̂AFFOR considers
a two-component mixture data structure. This mixture structure facilitates accounting for
the fever killing effect and measurement error that will be discussed in the following section.
3 FEVERKILLING EFFECT ANDMEASUREMENT
ERROR
Under Assumptions 1-3, we can estimate the MAFF by using observable quantities through
computing M̂AFFRR (or M̂AFFOR) from the discussed approaches in Section 2.3. How-
ever, Assumption 3 (the no errors assumption) is generally implausible becasue of fever
killing and measurement error. Fever killing refers to the fact that a fever kills some par-
asites in the body and measurement error refers to the fact that it is difficult to measure
parasite density with great accuracy. In this section, we provide a model describing fever
killing and measurement error, and show the effect of these problems on the performance
of the existing methods.
To account for fever killing and measurement error, we consider three different variables
related to the parasite density: Dno.nmii , D
cur
i and D
obs
i . Let D
no.nmi
i be the parasite density
that a subject i would have if the subject does not have a non-malaria infection strong
enough to cause a fever (Small et al. 2010), and let Dcuri be the amount of the parasite
density in blood of the subject after fever killing occurs. Also, let Dobsi be the observed
parasite density. If a subject i has a fever that is solely caused by a non-malaria infection,
Y nmii = 1, Y
mi
i = 0, then there is evidence that fever kills some of the parasites that would
have remained alive in the absence of the infection (Kwiatkowski 1989, Rooth & Bjorkman
1992, Long et al. 2001). In particular, Long et al. (2001) estimate that a fever of 38.8◦C
kills 50 % of parasites and a fever of 40◦C kills 92 % of parasites. Fever killing will make
Dno.nmii greater than the actual current parasite density. We note that D
no.nmi
i = D
cur
i
unless Y nmii = 1, Y
mi
i = 0. See Small et al. (2010) for more discussion on fever killing.
Fever killing occurs in some sense for all fevers, however we define Dno.nmii for malarial
fevers (Y mii = 1) in such a way that fever killing in terms ofD
cur
i being different fromD
no.nmi
i
occurs only for non-malarial fevers Y nmii = 1, Y
mi
i = 0 Specifically, we define D
no.nmi
i in the
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following way for a child with a malarial fever, Y mii = 1. In a malaria infection that is not
brought under control by a child’s immunity, the parasites multiply inside the red blood
cells they invade, eventually causing the red blood cell to rupture, and the released parasites
then invade new red blood cells (Kitchen 1949). This causes an exponential growth phase
of the parasites that terminates shortly after the onset of periodic fever (Kitchen 1949).
The fever starts killing parasites while at the same time the parasites that remain alive
continue to multiply. The clash of these two forces and the features of the parasite life
cycle cause the parasite density to oscillate (Kwiatkowski & Nowak 1991). For a child with
a malaria fever Y mii = 1, even if any non-malarial infection were removed, this process
of the parasites multiplying and eventually rising above the pyrogenic threshold and then
oscillating would occur. For a child with a malarial fever, we define the child’s parasite
density Dno.nmii = D
cur
i as the parasite density at the point in the child’s fever at which the
child is observed.
Besides fever killing, measurement error occurs when researchers measure the actual
current parasite density Dcuri . Let D
obs
i be the observed (measured) parasite density from
a blood sample. Dowling & Shute (1966) and O’Meara et al. (2007) study the sources and
magnitude of measurement error. The sources include the following: (1) Sample variabil-
ity. The parasite density is estimated from a sample of blood; (2) Loss of parasites in the
sample handling and staining process; (3) Microscopy error. The accuracy of the parasite
density measurement depends on the quality of the microscope and the concentration and
motivation of the microscopist; (4) Sequestration and synchronization. Microscopic exam-
ination of a blood sample only estimates the parasite density in the peripheral blood and
not the total parasite density. Older parasites sequester in the vascular beds of organs.
Due to a tendency of the life cycles of the parasites to be synchronized, there can be large
variation in the parasite density in the peripheral blood relative to the total parasite den-
sity (Bouvier et al. 1997); (5) Variability in white blood cell density. The most common
method of estimating parasite density counts the number of parasites found for a fixed
number of white blood cells and then assumes that there are 8000 white blood cells per µl
of blood. White blood cell counts actually vary considerably from person to person and
from time to time within a person (McKenzie et al. 2005).
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Figure 1: Causal diagram
Figure 1 summarizes the relationship between all the defined variables. As can be seen,
Dno.nmii is the only parasite density variable that decides whether child i has a malaria
fever or not while Dcuri and D
obs
i are proxy variables of D
no.nmi
i . We can think of D
no.nmi
i
as the parasitological challenge faced by the child which is a function of the amount of the
parasites injected from mosquito bites and the immune response of the child. The other
two parasite density variables, Dcuri and D
obs
i , change according to both fever killing and
measurement error but do not directly affect whether the child has a malarial fever.
3.1 Simulation Study of Existing Methods
We evaluate the performance of several existing methods for estimating the MAFF with a
simulation study. Specifically, we consider three settings; (1) there is no fever killing and
no measurement error (we call it Situation 1), (2) there is no fever killing effect, but there is
measurement error (Situation 2) and (3) there is both fever killing (50%) and measurement
error (Situation 3). We consider the four estimation methods discussed in Section 2: logistic
regression (L), logistic regression with power parameter (P), local linear smoothing followed
by isotonic regression (LI) and the adjusted semiparametric method (S). The first three
methods (L, P and LI) have probability limits of plim(M̂AFFRR). The semiparametric
model method has a probability limit of plim(M̂AFFOR), so we use adjustment (6) to
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Table 1: Means of estimates of the MAFF in Situation 1, 2 and 3 with 1000 simulations:
Neither fever killing nor measurement error (Situation 1) No fever killing, but measurement
error (Situation 2) and 50% fever killing and measurement error (Situation 3), True MAFF
is 0.5.
S P L LI
Situation 1 0.499 0.449 0.470 0.507
Situation 2 0.469 0.442 0.386 0.476
Situation 3 0.334 0.286 0.258 0.370
obtain an estimate of plim(M̂AFFOR). We call this estimate the adjusted semiparametric
method. The true MAFF is fixed as 0.5 across the simulation study; the true model is the
first scenario described in Section 5 with sample size n = 500 and endemicity 0.2.
Table 1 shows the performance of the four estimators in the three situations. In Sit-
uation 1, the adjusted semiparametric method (S) and the nonparametric method (LI)
produce estimates that are approximately unbiased; however, the other two methods pro-
duce biased estimates. This biased estimation for P and L is because the two methods rely
on certain model assumptions and the true model in the simulation does not satisfy these
model assumptions. In Situation 2 and 3, all estimators are significantly biased from the
true value 0.5. In Situation 2, the increased magnitude of biases compared to Situation
1 can be understood as biases caused by measurement error. Also, the further increase
in magnitude of bias in Situation 3 compared to Situation 2 represent biases caused by
50% fever killing. The combination of both fever killing and measurement error severely
degrades the performance of the existing methods. Although the nonparametric method
provides a good estimate of the MAFF in the absence of fever killing and measurement
error, it performs poorly in the presence of both problems. The existing methods fail to
provide unbiased estimates of the MAFF when Assumption 3 is violated.
Both the fever killing effect and measurement error are obstacles to obtain accurate
measures of the parasitological challenge Dno.nmii faced by a child. The failure to measure
Dno.nmii makes estimation of either P (Y = 1|D
no.nmi) or f(Dno.nmi|Y = 1) biased, thus
resulting in a biased estimate of the MAFF as can be seen in Table 1. In Section 5, more
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simulation results are displayed in various simulation settings. In the following section,
we propose our new estimation method to account for both fever killing and measurement
error by considering how to recover Dno.nmii from D
obs
i .
4 NEW ESTIMATION METHOD
4.1 Notation, Data structure and the Bayes deconvolution prob-
lems
We assume that the size of the fever killing effect and the measurement error mechanism
are known to researchers; if these are unknown, they can be varied in a sensitivity analysis.
To model the fever killing effect, we use a parameter β for the size of the effect; if β = 0.1,
then the non-malaria caused fever kills 90% of parasites. Fever killing occurs only when
Y nmii = 1, Y
mi
i = 0. Therefore, D
cur
i is equal to βD
no.nmi
i if Y
nmi
i = 1, Y
mi
i = 0, and D
cur
i is
the same as Dno.nmii otherwise.
For measurement error, let f be the measurement error mechanism. Dobsi has the density
function f with the parameter Dcuri , i.e. D
obs
i |D
cur
i ∼ f(x;D
cur
i ). For example, one way to
measure malaria parasites is to count the number of parasites in a fixed volume of sampled
blood (Earle et al. 1932); this measurement method was advocated by McKenzie et al.
(2005). If this measurement error method is used and the only source of measurement
error is the sampling of blood, then Dobs|Dcur ∼ Poisson(Dcur).
The assumptions of a known 100(1−β)% fixed size of fever killing and known measure-
ment error mechanism f allow us to estimate the MAFF through a Bayes deconvolution
approach under Assumptions 1 and 2. We do not assume the implausible assumption 3 of
no errors. The observed data (Y obsi , D
obs
i ) can be split into a febrile sample (Y
obs
i = 1) and
an afebrile sample (Y obsi = 0). We define
Dno.nmii = x|Y
mi
i = 0 ∼ g1(x)
Dno.nmii = x|Y
mi
i = 1 ∼ g2(x).
(7)
where g1 and g2 are density functions. Given Y
mi
i = 1, a child imust have a positive number
of parasites in her blood. Therefore, g2(0) must be zero. This restriction is considered in
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our estimation method in Section 4.2. Since the variables Y nmii and Y
mi
i are independent
from Assumption 2 (iii), we have Dno.nmii = x|Y
mi
i = 0, Y
nmi
i = 0 ∼ g1(x) and D
no.nmi
i =
x|Y mii = 0, Y
nmi
i = 1 ∼ g1(x). Similarly, D
no.nmi
i = x|Y
mi
i = 1, Y
nmi
i = 0 ∼ g2(x) and
Dno.nmii = x|Y
mi
i = 1, Y
nmi
i = 1 ∼ g2(x). Therefore, the D
no.nmi
i variable for the febrile and
afebrile populations are distributed as
Dno.nmii = x|Y
obs
i = 0 ∼ g1(x)
Dno.nmii = x|Y
obs
i = 1 ∼ (1− λ
∗)g1(x) + λ
∗g2(x).
(8)
where λ∗ is the mixing proportion {P (Y mii = 1, Y
nmi
i = 0)+P (Y
mi
i = 1, Y
nmi
i = 1)}/P (Y
obs
i =
1) = P (Y mii = 1)/P (Y
obs
i = 1). Next, by considering the 100(1 − β)% fever killing effect,
the Dcuri variable is given by
Dcuri = x|Y
obs
i = 0 ∼ g1(x)
Dcuri = x|Y
obs
i = 1 ∼ (1− λ
∗)g∗1(x) + λ
∗g2(x).
(9)
where g∗1(x) = g1(x/β). Finally, using the measurement error mechanism f , the D
obs
i
variable is distributed as
Dobsi = x|Y
obs
i = 0 ∼ (f ◦ g1)(x)
Dobsi = x|Y
obs
i = 1 ∼ (1− λ
∗)(f ◦ g∗1)(x) + λ
∗(f ◦ g2)(x).
(10)
The composite functions (f ◦ g∗1)(x) and (f ◦ g2)(x) can be observed and estimated from
data. Dno.nmii is a random sample from unknown density g1 (or g2). D
no.nmi
i independently
produces an observed random variable Dobsi according to a known density f . When the
density f is known, estimating the prior densities g∗1 and g2 from the composite functions
(f ◦ g∗1) and (f ◦ g2) is often called the Bayes deconvolution problem (Efron 2016). We
note that the usual additive measurement error problem is a special case of the Bayes
deconvolution problem.
To tackle the Bayes deconvolution problem, we apply the exponential family “g-modeling”
approach in Efron (2016) to the malaria data. The g-modeling approach assumes that the
distributions g1(x) and g2(x) belong to exponential family distributions. Efron shows that
parametric exponential family modeling can give useful estimates in moderate-sized samples
while traditional asymptotic calculations are discouraging, indicating very slow nonpara-
metric rates of convergence. Although this approach assumes a parametric model, it can
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be made more flexible by increasing the number of parameters as the sample size increases.
With enough parameters, the risk of model misspecification is reduced.
Another approach to the Bayes deconvolution problem is to model the densities (f ◦
g1)(x) and (f ◦ g2)(x) directly (called “f-modeling” in Efron (2014) ). The f-modeling ap-
proach is not considered in this article because the g-modeling approach is more straight-
forward to capture the fever killing effect. Knowing g1(x) implies knowing g1(βx), but this
is not true in the f-modeling approach. Furthermore, g-modeling is more efficient than
f-modeling (Efron 2016).
4.2 Estimation
First, we discretize the Dcur space for the afebrile sample and the febrile sample separately.
To be specific, considering the 100(1− β)% fever killing effect, we define the discrete sets
of Dcura and D
cur
f for the afebrile population and febrile population respectively;
Dcura = {d1, ..., dk}, D
cur
f = {βd1, ..., βdk}.
Since the parasite level is always greater than or equal to zero, the element d1 of the discrete
set is zero. We note that we can use continuous formulation instead of using discretization.
However, this discretization is essentially necessary because the numerical implementation
of the theory is required to obtain the maximum likelihood estimates.
The g-modeling approach assumes that the distributions g1, g
∗
1 and g2 are the expo-
nential family distributions. Also, we assume that both distributions g1 and g
∗
1 share the
common parameters because of g1(x) = g
∗
1(βx). Assume that the densities of g1, g
∗
1 and g2
are
g1(dj;α1) = exp{Q1jα1 − φ1(α1)} , j = 1, ..., k
g∗1(βdj;α1) = g1(dj;α1) , j = 1, ..., k
g2(βdj;α2) = exp{Q2jα2 − φ2(α2)} , j = 1, ..., k
(11)
where (1) α1 is a m1-dimensional parameter vector and α2 is a m2-dimensional parameter
vector, (2) Q1j and Q2j are j-th rows of the known matrices Q1 and Q2 respectively and
(3) φ1(α1) and φ2(α2) are chosen to satisfy
∑k
j=1 g1(dj;α1) =
∑k
j=1 g2(βdj;α2) = 1. Q1 is
a k ×m1 matrix and Q2 is a k ×m2 matrix. The matrices Q1 and Q2 are determined by
the sample spaces Dcura and D
cur
f respectively, and they can be constructed by using the
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natural spline R function ‘ns’; the matrix Q1 is obtained from ‘ns(D
cur
a , df=m1)’, and the
matrix Q2 is obtained from ‘ns(D
cur
f , df=m2)’. Then, the matrices are standardized so that
each column has mean zero and sum of squares one. For further computational details, see
Efron (2016).
Given the density functions, the probability of having an observation xi in the afebrile
sample is
P (Dobsi = xi|Y
obs
i = 0) =
k∑
j=1
P (Dobsi = xi|D
cur
i = dj)g1(dj;α1) =
k∑
j=1
f(xi; dj)g1(dj;α1)
and in a similar fashion, the probability of having an observation xi in the febrile sample is
P (Dobsi = xi|Y
obs
i = 1) =
∑k
j=1 P (D
obs
i = xi|D
cur
i = βdj) · {(1− λ
∗)g∗1(βdj;α1) + λ
∗g2(βdj;α2)}
=
∑k
j=1(1− λ
∗)f(xi; βdj)g
∗
1(βdj;α1) + λ
∗f(xi; βdj)g2(βdj;α2).
(12)
Then, the likelihood L(p, λ∗, α1, α2) is written as
L(p, λ∗, α1, α2) =
∏n
i=1 P (D
obs
i = xi, Y
obs
i = yi)
=
∏n
i=1
[
{P (Dobsi = xi|Y
obs
i = 1)P (Y
obs
i = 1)}
I(Y obsi =1)
×{P (Dobsi = xi|Y
obs
i = 0)P (Y
obs
i = 0)}
I(Y obsi =0)
]
.
(13)
and the log-likelihood ℓ(p, λ∗, α1, α2) is written as
ℓ(p, λ∗, α1, α2) =
∑n
i=1 I(Y
obs
i = 0) · {log(1− p) + logP (D
obs
i = xi|Y
obs
i = 0;α1)}
+I(Y obsi = 1) · {log p+ logP (D
obs
i = xi|Y
obs
i = 1;λ
∗, α1, α2)}
=
∑n
i=1 I(Y
obs
i = 0) · log(1− p) + I(Y
obs
i = 1) · log p
+I(Y obsi = 0) · log{
∑k
j=1 f(xi; dj)g1(dj;α1)}
+I(Y obsi = 1) · log{
∑k
j=1(1− λ
∗)f(xi; βdj)g
∗
1(βdj;α1) + λ
∗f(xi; βdj)g2(βdj;α2)}.
(14)
The estimates λˆ∗ and pˆ can be obtained by maximizing the log-likelihood ℓ(p, λ∗, α1, α2).
Then, the estimate λˆ of the MAFF is obtained from λˆ∗ and pˆ, λˆ = (λˆ∗− pˆλˆ∗)/(1− pˆλˆ∗) by
using adjustment (6).
Also, Efron (2016) suggests to use a penalized likelihood as he finds that the accu-
racy of a deconvolution estimate obtained from the g-modeling approach can be greatly
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improved by regularization of the maximum likelihood algorithm. Instead of maximizing
ℓ(p, λ∗, α1, α2), we maximize a penalized log-likelihood
m(p, λ∗, α1, α2) = ℓ(p, λ
∗, α1, α2)− s(α1, α2)
where s(α1, α2) is a penalty function. In this article, the function s(α1, α2) is
s(α1, α2) = c0(||α1||
2 + ||α2||
2)1/2
where c0 is a regularizing constant. The choice of c0 is related to bias-variance tradeoff.
Efron (2016) suggests c0 = 1 as a modest choice that restricts the trace of the added
variance due to the penalization.
For the computation, an equispaced discretization is used. The ‘optim’ R package is
used to find the maximum likelihood estimates by restricting p and λ∗ inside the interval
(0,1). This restriction can be done by using ‘L-BFGS-B’ method option in the optim
function. The R code file for this estimation approach is provided in the Supplementary
Materials.
4.3 Sensitivity Analysis for Assumption 2
Our proposed estimation method relies on Assumption 2, particularly, Assumption 2 (iii)
and (iv) that assume Y mii and Y
nmi
i have independent causal pathways that form a parallel
circuit to trigger a fever, in order to deal with the mixture problem. However, these
assumptions could potentially be violated. For example, if a child has a non-malarial
infection, but it is not strong enough to trigger a non-malarial fever (Y nmii = 0), then the
parasite density just below the threshold (Y mii = 0) can trigger a fever (Y
obs
i = 1) because
a combined effect of some malaria parasites and some non-malarial infections that make
the child’s immune system weaker might be enough to trigger a fever. In this scenario that
violates Assumption 2 (iv), if all the malaria parasites in the child’s blood are removed,
then the non-malarial infection will be still below the threshold T nmii , and the observed
fever Y obsi will be removed. Therefore, the child has a fever attributable to malaria, but
Y mii does not correctly describe this malaria attributable fever.
To propoerly describe this scenario, we instead consider a modified pyrogenic threshold
variable T ∗i (Zi) which is a decreasing function of the non-malarial infection level Zi and
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Figure 2: Comparison of separation by Y mi and Y nmi and separation by Y mi,∗ and Y nmi.
T ∗i (0) = T
mi
i and consider a new variable Y
mi,∗
i , which is I(Di ≥ T
∗
i (Zi)) if Zi < T
nmi
i and
is I(Di ≥ T
∗
i (0)) if Zi ≥ T
nmi
i . Figure 2 displays the difference between Y
mi
i and Y
mi,∗
i .
Y mii = 1 indicates the area above the horizontal dashed line and Y
mi,∗
i = 1 indicates the
dotted area above the solid line. Y mii is equal to Y
mi,∗
i if Zi ≥ T
nmi
i by definition. We note
that the definition of the MAFF does not depend on how to separate Y nmi = 1, Y mi = 1
and Y nmi = 1, Y mi = 0 because the MAFF only depends on the proportion of Y nmi = 0
given Y obs = 1. Therefore, Y mi has no role in defining the MAFF. Like Y mii , Y
mi,∗
i is a
nuisance variable and is used to separate the area of Y nmii = 1.
We can use the same estimation method described in Section 4.2 if Y nmii and Y
mi,∗
i sat-
isfy Assumption 2. However, both Y nmii and Y
mi,∗
i depend on the amount of non-malarial
infections Zi, and they are dependentm which means Assumption 2 (iii) would be violated
with Y mi,∗i in place of Y
mi
i . One way to mitigate this violation of the independence assump-
tion of Y nmii and Y
mi,∗
i is to conduct a sensitivity analysis. The violation affects two relation-
ships: the relationship between the parasite densities f(Dno.nmii = x|Y
mi,∗
i = 0, Y
nmi
i = 0)
and f(Dno.nmii = x|Y
mi,∗
i = 0, Y
nmi
i = 1) and the relationship between the probabilities
P (Y nmii = 0|Y
mi,∗
i = 1) and P (Y
nmi
i = 0|Y
mi,∗
i = 0). Under the independence assumption,
the two densities are equal and the two probabilities are equal. However, if the indepen-
dence assumption does not hold, then the relationships are not identified. To identify the
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MAFF, we need sensitivity parameters to describe and restrict the relationships.
The relationship between f(Dno.nmii = x|Y
mi,∗
i = 0, Y
nmi
i = 0) and f(D
no.nmi
i =
x|Y mi,∗i = 0, Y
nmi
i = 1) can be described by using an exponential tilt model,
f(Dno.nmii = x|Y
mi,∗
i = 0, Y
nmi
i = 1) = exp(δ0 + δ1x)f(D
no.nmi
i = x|Y
mi,∗
i = 0, Y
nmi
i = 0).
where δ0 and δ1 are known. If δ1 is known, δ0 is identified because of
∫∞
0
f(Dno.nmii =
x|Y mi,∗i = 0, Y
nmi
i = 1) = 1dx, and is a function of δ1. We use δ1 as a sensitivity parameter.
The g-modeling method assumes the parasite density f(Dno.nmii = dj|Y
mi,∗
i = 0, Y
nmi
i =
0) = exp{Q1jα1−φ1(α1)} where φ1(α1) = log
(∑k
j=1 exp{Q1jα1}
)
. Therefore, the parasite
density f(Dno.nmii = dj|Y
mi,∗
i = 0, Y
nmi
i = 1) is represented as
exp(δ0 + δ1dj) exp{Q1jα1 − φ1(α1)} = exp{(δ1dj +Q1jα1) + (δ0 − φ1(α1))},
and δ0 is chosen as δ0 = log
(∑k
j=1 exp{Q1jα1}
)
− log
(∑k
j=1 exp{Q1jα1 + δ1dj}
)
. From
the definition of Y mi,∗i , it is evident that the proportion of low parasites when Y
mi,∗
i =
0, Y nmii = 0 is always higher than that when Y
mi,∗
i = 0, Y
nmi
i = 1, which can be seen
visually in Figure 2. This restricts the sensitivity parameter δ1 to satisfying the inequality
δ1 ≥ 0. For the relationship between P (Y
nmi
i = 0|Y
mi,∗
i = 1) and P (Y
nmi
i = 0|Y
mi,∗
i = 0),
we use a sensitivity parameter τ as the ratio of the probabilities τ = P (Y nmii = 0|Y
mi,∗
i =
1)/P (Y nmii = 0|Y
mi,∗
i = 0). From the definition of Y
mi,∗
i , τ should be above 1, i.e. τ ≥ 1.
We conduct a sensitivity analysis by using the sensitivity parameter δ1 and τ in Section 6 to
investigate the impact of the violation of Assumption 2 (iii) on the estimate of the MAFF.
The independence assumption can also be violated when Y nmii and D
no.nmi
i are depen-
dent because of confounding variables. If these confounders are observed covariates such
that Y nmi and Dno.nmo are conditionally independent given these observed covariates, then
we can estimate the MAFF by extending our proposed method to incorporate the ob-
served covariate. Let the observed covariates be denoted by the r-dimensional vector Oi.
In the presence of covariates, rather than allowing any function for f , we assume a one-
parameter exponential family of conditional densities for each Oi; f(D
no.nmi
i |D
cur
i , Oi) =
exp {Dno.nmii · ηi − ψ(ηi)} where ηi = D
cur
i + O
T
i γ is a linear combination of D
cur
i and Oi,
and γ is an unknown r-dimensional parameter vector (Efron 2016). The functional form
is known, but the parameter vector γ is not. Therefore, γ has to be estimated in the
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estimation procedure. In addition to a unknown m-dimensional parameter vector α for
g(Dcuri ;α), (α, γ) can be estimated by maximizing the likelihood function as we discussed
in Section 4.2.
5 SIMULATION STUDY
In this section, we evaluate the performance of our proposed method including the regular
likelihood approach and the penalized likelihood approach in a simulation study. It was
shown in Section 3.1 that the existing methods produce biased estimates of the MAFF when
there is fever killing and measurement error. In addition to evaluating the performance
of our proposed method, we compare it to the existing methods by considering various
simulation settings. The distribution of g1 is a mixture of a point mass at zero and a
distribution for positive parasite levels and the distribution of g2 satisfies g2(0) = 0. We
consider two scenarios; (i) g1 and g2 are exponential family distributions and (ii) g1 and g2
are not exponential family distributions. For the first scenario, we assume
g1(x) = q · I(x = 0) + (1− q) · TN(0,∞)(µ1, σ1)
where q is the proportion of zero parasite level and TN(0,∞)(µ, σ) is a truncated normal
distribution with mean µ and standard deviation σ in the interval (0,∞). The distribution
of g∗1(x) is implicitly defined as
g∗1(x) = q · I(x = 0) + (1− q) · TN(0,∞)(βµ1, βσ1),
and the distribution of g2 can only take positive parasite levels,
g2(x) = TN(0,∞)(µ2, σ2).
The second scenario considers uniform distributions, which are not in exponential family
distributions. To be specific, g1(x) = q1 · I(x = 0) + (1 − q1)q2 · TN(0,∞)(µ1, σ1) + (1 −
q1)(1 − q2) · U(0, 2µ1) and g2(x) = q2 · TN(0,∞)(µ2, σ2) + (1 − q2) · U(0, 2µ2) where U(a, b)
is the uniform distribution in the interval (a, b). Throughout the simulation study, the
probability q1 is fixed as 1/8. The number of the parameters is chosen as m1 = 4 for g1 and
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Table 2: Exponential family distribution case. Means (standard deviations) of the estima-
tors in simulation settings are displayed; P represents the power model regression method,
S represents the adjusted semiparametric method, and LI represents the nonparametric
method. True MAFF is 0.5
MAFF
n q β Regular Penalized P S LI
500 0.2 1 0.501 (0.120) 0.488 (0.118) 0.443 (0.089) 0.471 (0.083) 0.475 (0.078)
0.8 0.499 (0.117) 0.487 (0.112) 0.406 (0.102) 0.437 (0.089) 0.441 (0.081)
0.2 0.512 (0.056) 0.491 (0.045) 0.119 (0.037) 0.138 (0.064) 0.143 (0.059)
0.8 1 0.499 (0.028) 0.497 (0.028) 0.485 (0.027) 0.487 (0.026) 0.483 (0.025)
0.8 0.498 (0.028) 0.495 (0.028) 0.483 (0.027) 0.485 (0.027) 0.480 (0.025)
0.2 0.499 (0.024) 0.495 (0.022) 0.453 (0.025) 0.457 (0.024) 0.444 (0.020)
1000 0.2 1 0.499 (0.081) 0.490 (0.082) 0.440 (0.063) 0.468 (0.058) 0.472 (0.055)
0.8 0.500 (0.076) 0.490 (0.072) 0.406 (0.072) 0.437 (0.062) 0.438 (0.057)
0.2 0.507 (0.039) 0.495 (0.031) 0.117 (0.022) 0.138 (0.039) 0.135 (0.042)
0.8 1 0.498 (0.020) 0.496 (0.020) 0.484 (0.019) 0.486 (0.019) 0.482 (0.018)
0.8 0.498 (0.020) 0.497 (0.020) 0.483 (0.019) 0.485 (0.018) 0.480 (0.017)
0.2 0.499 (0.017) 0.497 (0.016) 0.455 (0.018) 0.458 (0.017) 0.446 (0.015)
m2 = 3 for g2. Also, we assume that we know the Poisson measurement error mechanism
Dobs ∼ Pois(Dcur) i.e. the mechanism f(x) is the standard Poisson distribution.
In addition, we consider the following three factors that may affect the performance of
our method.
1. Size of fever killing effect. Three different sizes of the fever killing effect are considered.
The settings are large fever killing effect (fever kills approximately 80% of parasites
which means β = 0.2), small fever killing effect (fever kills approximately 20% of
parasites, β = 0.8) and no fever killing effect (β = 1). The no fever effect case will be
used as a standard for comparison between the other two fever killing effects settings.
2. Endemicity. Endemic regions differ greatly by how many people have the malaria
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Table 3: Non-exponential family distribution case. Means (standard deviations) of the
estimators in simulation settings are displayed; P represents the power model regression
method, S represents the adjusted semiparametric method, and LI represents the nonpara-
metric method. True MAFF is 0.5
MAFF
n q β Regular Penalized P S LI
500 0.2 1 0.492 (0.116) 0.499 (0.126) 0.423 (0.094) 0.458 (0.087) 0.466 (0.081)
0.8 0.488 (0.112) 0.503 (0.121) 0.379 (0.103) 0.420 (0.091) 0.430 (0.080)
0.2 0.516 (0.062) 0.517 (0.071) 0.123 (0.033) 0.133 (0.060) 0.140 (0.055)
0.8 1 0.498 (0.029) 0.501 (0.029) 0.480 (0.027) 0.482 (0.027) 0.478 (0.026)
0.8 0.497 (0.030) 0.499 (0.031) 0.479 (0.027) 0.481 (0.026) 0.475 (0.025)
0.2 0.501 (0.025) 0.505 (0.027) 0.451 (0.025) 0.454 (0.024) 0.441 (0.021)
1000 0.2 1 0.502 (0.091) 0.499 (0.095) 0.420 (0.065) 0.454 (0.060) 0.462 (0.055)
0.8 0.498 (0.090) 0.498 (0.093) 0.379 (0.074) 0.421 (0.063) 0.430 (0.056)
0.2 0.503 (0.051) 0.493 (0.040) 0.125 (0.022) 0.138 (0.038) 0.137 (0.040)
0.8 1 0.497 (0.020) 0.497 (0.020) 0.481 (0.019) 0.483 (0.018) 0.478 (0.018)
0.8 0.498 (0.022) 0.498 (0.022) 0.480 (0.019) 0.482 (0.019) 0.476 (0.018)
0.2 0.501 (0.019) 0.498 (0.020) 0.450 (0.017) 0.453 (0.017) 0.440 (0.015)
parasites in their blood. Endemicity could affect the variance of the estimate of
the MAFF. Two levels of endemicity are considered: mesoendemic q = 0.8 (low to
moderate) and holoendemic q = 0.2 (high).
3. Sample size n. Two sample sizes, n = 500 and n = 1000, are considered.
There are 3× 2× 2 = 12 settings for each scenario to investigate the effect of the settings
on the performance of our proposed method.
We use both the regular likelihood approach and the penalized likelihood approach to
estimate the MAFF and compare them to the existing methods that do not account for
fever killing and measurement error. Table 2 shows the means and standard deviations of
the maximum likelihood estimates in the various settings when the true models are in the
25
Table 4: Summary of the data from Kilombero, Tanzania
Parasite level Afebrile Febrile
= 0 160 16
> 0 1698 121
Total 1858 137
exponential family. The means and the standard deviations of the estimates are obtained
from 1000 repetitions. Three aspects are found in this table. First, both the regular likeli-
hood and the penalized likelihood approaches provide approximately unbiased estimates of
the true MAFF while other existing methods (P, S, LI) are biased. There is a trend that
the regular likelihood estimates have lower bias and slightly larger standard deviations than
the penalized likelihood estimates. This is because the true models are exponential fam-
ily distributions. Second, the larger proportion of zero parasite level contributes to more
efficient estimates. That is, the estimate of the MAFF in mesoendemic regions is more
efficient than the estimate in holoendemic regions. Finally, as sample size n increases, both
the approaches produce estimates which are closer to the true MAFF value 0.5 (less bias)
and have smaller standard deviations.
Table 3 displays the means and standard deviations of the estimates when the true
models are not exponential family distributions. As can be seen in Table 3, a larger n
and a larger q contribute to a smaller standard deviation. A smaller β leads to a smaller
standard deviation, but it also leads to a bias. A different aspect in Table 3 compared to
Table 2 is that the penalized likelihood approach generally performs better with smaller
standard deviations than the regular likelihood approach in the non-exponential family
distribution case of Table 3.
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6 APPLICATION: DATA FROMKILOMBERO, TAN-
ZANIA
We consider data from a study of children in the Kilombero District (Morogoro Region) of
Tanzania (Smith et al. 1994). The study collected parasite density levels and the presence
of fever among 426 children under six years of age in two villages from June 1989 until
May 1991 in the Kilombero District (Morogoro Region) of Tanzania. This area is highly
endemic for Plasmodium falciparum malaria. A total of 1996 blood films from the 426
children were examined. Smith et al. (1994) found that the correlation between consecutive
observations on the same child is not significant and the impact of the correlation on
the MAFF is negligible. We will follow Smith et al. (1994) in assuming that the 1996
collected observations are independent and for brevity will describe the data as involving
1996 children. In this dataset, there are n1 = 137 children who had a fever and n0 =
1859 children who did not have a fever. The former is a group of febrile children whose
fever was caused by either malaria infection or non-malaria infection. The latter is a
group of afebrile controls that is used to provide information on the parasite density of
the non-malaria infection population. Table 4 summarizes the data. The proportions of
zero parasite level is 0.086 = 160/1858 and 0.117 = 16/137 in the afebrile and febrile
groups respectively. Under the no errors assumption (Assumption 3) and the monotonicity
assumption in Assumption 2, the proportion of zero parasite density level in the afebrile
group must be greater than that in the febrile group so the proportions in Table 4 suggest
some violations of the assumptions.
Also, in the absence of measurement error and fever killing, under Assumption 2, the
probability of a fever should be monotonically increasing in the parasite density. Figure 3
shows the relationship between probability of fever and parasite density and also suggests
a violation of the assumptions. Smith et al. (1994) point out that this phenomenon that
the probability of a fever is not monotonically increasing in the parasite density has been
observed in many other datasets, and consider it a consequence of non-malarial fevers
suppressing low density parasitaemia, i.e., fever killing.
The existing four estimation methods discussed earlier (L, P, IL, S discussed in Section 3)
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Figure 3: The relationship between parasite density and probability of fever. The solid
curve represents the point estimate across parasite density obtained by using penalized
splines, and the dashed curves are 95% pointwise confidence intervals.
can be used to estimate the MAFF from the malaria data in Tanzania, but the methods
do not account for the fever killing effect and measurement error problems that we have
described in Section 3. Under the assumption of the absence of the fever killing effect and
measurement error, the estimates of the MAFF from the existing methods are 0.176 (L),
0.202 (P), 0.177 (LI) and 0.177 (S) shown in the bottom of Table 5. The displayed standard
deviations are computed from 2000 bootstrapped samples.
To apply our proposed method, a measurement error mechanism needs to be specified.
In the Kilombero study, the number of parasites is counted in a predetermined number
of white blood cells (WBCs), usually 200, and then the parasite density per µl is esti-
mated as 40 times the count, under the assumption that there are 8000 WBCs per µl.
The simplest choice is the Poisson measurement error mechanism. The Poisson measure-
ment error mechanism will hold if the only source of measurement error is the sampling
of parasites from 1/40 µl of blood and parasites are uniformly distributed throughout
the blood. Without any other sources of measurement error but this sampling error, the
measurement error model would be (M1) f1(D
obs|Dcur) ∼ Poisson(Dobs/40;Dcur/40). As
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we discussed in Section 3, microscopy error is another source of measurement error as
well as sampling error. A more complicated model than the Poisson model to account
for the microscopy error is a negative binomial measurement error model. The nega-
tive binomial (NB) model is (M2) f2(D
obs|Dcur) ∼ NB(Dobs/40; r, r/(r +Dcur/40)) where
r is the dispersion parameter. From O’Meara et al. (2007), we estimate the dispersion
parameter is r = 6. The estimation process is shown in Appendix A.3. Furthermore,
another source of measurement error is WBCs count variability; the number of WBCs per
µl is not fixed as 8000, but varies from person to person (McKenzie et al. 2005). Based
on McKenzie et al. (2005), we consider a discrete distribution h(x) of WBCs counts per
µl: Point masses of (4, 5, 6, 7, 8, 9, 10, 11, 12)× 103 = (.12, .16, .20, .16, .16, .10, .04, .04, .02).
The distribution h(x) accounts for the potential effect of the variability of WBCs counts.
The most complicated measurement error model (M3) in our simulation study combines
the microscopy error and the WBC count variability, and is f3(D
obs|Dcur) ∼
∑
h(x)·
NB(Dobs/(x/200); r, r/(r +Dcur/(x/200))). We note that the distribution f1 has the small-
est variance and the distribution f3 has the largest variance. The models (M1)-(M3) are
considered and compared in our analysis.
In addition to the measurement error mechanism, the size of fever killing 1 − β needs
to be specified, but it is not known precisely based on current scientific knowledge. We
consider a series of various plausible fever killing sizes, and calculate the corresponding
estimates of the MAFF; the series of fever killing sizes ranges from no fever killing to 95%
fever killing in the increment 0.05, i.e., the sequence of β is (0.05, 0.10, . . . , 0.95, 1.00). We
do not consider no fever killing to be plausible but include it for comparison purposes.
Based on previous studies, we can shorten the plausible range of the size of fever killing
effect by using children’s temperature data. We found that the temperature data are dis-
tributed between 37.5◦C and 40◦C with 90% percentile 38.7◦C and 95% percentile 39.1◦C.
Long et al. (2001) found that when the temperature is 38.8◦C, the fever killing effect was
50% so we consider 50% an upper bound on the fever killing effect (i.e., the range of the
fever killing size is 1 − β ∈ (0, 0.5)). Furthermore, the assumption that has a fixed size of
fever killing across population can be eased by incorporating the temperature data into the
analysis by accounting for temperature-varying fever killing size. However, incorporating
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Table 5: Estimates of the MAFF. The upper table: the estimates corresponding to the
different sizes of fever killing; 1−β = 0.95 means 95% fever killing and 1−β = 0 means no
fever killing. The standard deviations are computed from 500 bootstrapped samples. The
lower table: the estimates from the existing methods.
MAFF MAFF
1− β M1 M2 M3 1− β M1 M2 M3
0.00 0.200 (0.057) 0.192 (0.056) 0.190 (0.057) 0.50 0.302 (0.056) 0.336 (0.054) 0.330 (0.053)
0.05 0.209 (0.056) 0.203 (0.050) 0.201 (0.050) 0.55 0.317 (0.061) 0.359 (0.057) 0.352 (0.056)
0.10 0.217 (0.053) 0.215 (0.048) 0.212 (0.052) 0.60 0.335 (0.066) 0.385 (0.064) 0.377 (0.063)
0.15 0.227 (0.046) 0.227 (0.052) 0.224 (0.052) 0.65 0.357 (0.064) 0.415 (0.067) 0.405 (0.064)
0.20 0.236 (0.050) 0.239 (0.052) 0.236 (0.049) 0.70 0.388 (0.076) 0.449 (0.068) 0.438 (0.069)
0.25 0.245 (0.049) 0.253 (0.054) 0.249 (0.051) 0.75 0.428 (0.072) 0.490 (0.075) 0.476 (0.076)
0.30 0.255 (0.049) 0.267 (0.054) 0.263 (0.049) 0.80 0.482 (0.086) 0.538 (0.083) 0.521 (0.080)
0.35 0.265 (0.051) 0.282 (0.050) 0.278 (0.050) 0.85 0.557 (0.082) 0.598 (0.082) 0.578 (0.086)
0.40 0.276 (0.048) 0.298 (0.050) 0.294 (0.052) 0.90 0.660 (0.073) 0.680 (0.073) 0.655 (0.071)
0.45 0.288 (0.054) 0.316 (0.055) 0.311 (0.055) 0.95 0.805 (0.052) 0.821 (0.053) 0.794 (0.054)
L P S LI
MAFF 0.176 (0.042) 0.202 (0.074) 0.177 (0.063) 0.182 (0.079)
the temperature data is beyond the scope of our paper.
Table 5 shows the estimates of the MAFF from the different values of the fever killing
effect parameter β for each measurement error model from (M1) to (M3). As the fever
killing effect becomes larger (i.e., β decreases), the estimate of the MAFF increases from
0.200 to 0.805 of the model (M1), the estimate increases from 0.192 to 0.821 of (M2), and the
estimate increases from 0.190 to 0.794 of (M3). Although the estimate from measurement
error mechanism (M1) is generally smaller than both that of (M2) and (M3), the variability
of these estimates for each fixed β is small. In the absence of the fever killing effect and
measurement error, the estimates from other model approaches were about 0.177, however,
the estimate of MAFF is inflated to about 0.190 after considering the measurement error
problem (no fever killing means that there is only measurement error). Moreover, when the
fever killing effect is severe such as 95% killing effect, the estimates of the MAFF are about
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Figure 4: The plot of the estimates of the MAFF on the fever killing parameter β for the
measurement error models (M1)-(M3).
0.8. Figure 4 visually shows the results of Table 5. The figure is plotting the estimates
of the MAFF vs. the values of 1 − β. As can be seen in Figure 4, the effect of fever
killing is moderate for a moderate size of fever killing, but a large killing effect boosts the
estimates of the models (M1)-(M3). One distinct pattern between the three measurement
error mechanism models is that the estimates of the models (M2) and (M3) are similarly
affected as a fever killing effect increases and are similar for every value of β.
In the analysis of the Tanzania malaria data, we have demonstrated that the estimate of
the MAFF not only depends on the fever killing size, but also depends on the measurement
error mechanism. To obtain more precise results, it is required to know both a plausible
range of the fever killing size and which type of measurement error occurs a priori.
We also conduct an additional sensitivity analysis for violation of Assumption 2 (iii). We
use two sensitivity parameters δ1 and τ discussed in Section 4.3. The sensitivity parameter
δ1 represents how two densities f(D
no.nmi
i = x|Y
mi,∗
i = 0, Y
nmi
i = 0) and f(D
no.nmi
i =
x|Y mi,∗i = 0, Y
nmi
i = 1) differ (δ1 = 0 means that the densities are equal), and the sensitivity
parameter τ represents the relative rate of not having a non-malarial fever according to
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Figure 5: Sensitivity Analysis for violation of Assumption 2. From top to bottom, the sizes
of fever killing are 20%, 50%, 80%. From left to right, the measurement error mechanisms
are M1, M2, M3. The estimates of the MAFF are represented as contour levels according
to the values of δ1 and τ . The scaled x-axis 40,000 ×δ1 is used rather than δ1 because
of 0 ≤ 40, 000 × δ1 ≤ 1. The difference between adjacent contour levels is 0.005 in every
sensitivity analysis.
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Y mi,∗i . We consider plausible ranges of the parameters: 0 ≤ δ1 ≤ 1/40, 000 (this range is
wide enough because the number of parasites is between 0 and 100,000) and 1 ≤ τ ≤ 1.06.
Figure 5 shows the estimates of the MAFF according to the values of δ1 and τ for a size of
fever killing β (β = 0.2, 0.5, 0.8) and a measurement error mechanism (M1, M2, M3). The
estimates are plotted by using contour plots. The effect of deviation from Assumption 2
(iii) is shown differently according to which factor caused a violation. As δ1 increases, the
estimate of the MAFF decreases and as τ increases, the estimate increases. Therefore, a
mixed effect of δ1 and τ appears to cancel each other out and to have a slight impact on the
estimate. Another noticeable pattern is that the impact of δ1 is severer than the impact of
τ when a fever killing effect is small, but this pattern is reversed when a fever killing effect
is large.
7 SUMMARY
In this article, we have proposed a new approach to estimate the MAFF in the presence of
both fever killing and measurement error. We have shown that existing MAFF estimators
can be substantially biased in the presence of these problems. We develop a new estima-
tor using the g-modeling approach to the Bayes deconvolution problem. To develop this
new estimator, we extended the existing g-modeling approach that solves the convolution
problem in non-mixture data to a setting of two-component mixture data such as malaria
data. Under the assumptions that the size of fever killing effect is known and measurement
error mechanism is known, our new estimator performs well. In practice, when the size of
the fever killing effect is not known, we recommend choosing a plausible range of the fever
killing size and comparing the corresponding estimates for a sensitivity analysis. To get
a better estimate of the MAFF, further research is needed to better understand the fever
killing effect to be able to get a narrower range of the fever killing size. Another difficulty
in practice is to specify the measurement error mechanism. This problem can be eased by
considering several plausible measurement error mechanism models from the simplest to
the most complicated as we did in Section 6. If a more complicated model produces a sim-
ilar estimate to that of a less complicated model in general, then we can be more confident
with our conclusion. More research on understanding the measurement error mechanism
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would also be useful.
A APPENDIX
A.1 Proof of Proposition 1
Since Y nmi does not depend on the parasite level D and P (Y mi = 1|D = 0) = 0, we can
have
P (Y obs = 1|D = 0) = P (Y nmi = 1, Y mi = 0|D = 0) + P (Y mi = 1|D = 0)
= P (Y nmi = 1)P (Y mi = 0|D = 0)
= P (Y nmi = 1)
(15)
Similarly, we have
P (Y obs = 1|D > 0) = P (Y nmi = 1|D > 0) + P (Y nmi = 0, Y mi = 1|D > 0)
= P (Y nmi = 1) + P (Y nmi = 0, Y mi = 1|D > 0)
(16)
Then, from Equations (15) and (16), M̂AFFRR is
M̂AFFRR = pf (R− 1)/R
= P (D > 0|Y obs = 1) · P (Y
obs=1|D>0)−P (Y obs=1|D=0)
P (Y obs=1|D>0)
= P (D > 0|Y obs = 1) · {P (Y
nmi=1)+P (Y nmi=0,Y mi=1|D>0)}−P (Y nmi=1)
P (Y obs=1|D>0)
= P (Y
obs=1,D>0)
P (Y obs=1)
P (Y nmi=0,Y mi=1|D>0)
P (Y obs=1|D>0)
= P (Y
nmi=0,Y mi=1,D>0)
P (Y obs=1)
= P (Y nmi = 0, Y mi = 1|Y obs = 1)
(17)
A.2 Proof of Proposition 2
Let R∗ be the odds ratio pf(1 − pa)/pa(1 − pf). Since pf = P (D > 0|Y
obs = 1) and
pa = P (D > 0|Y
obs = 0), the odds ratio R∗ is
R∗ =
pf
1−pf
· 1−pa
pa
= P (D>0|Y
obs=1)
P (D=0|Y obs=1)
· P (D=0|Y
obs=0)
P (D>0|Y obs=0)
= P (Y
obs=1,D>0)
P (Y obs=1,D=0)
· P (Y
obs=0,D=0)
P (Y obs=0,D>0)
= P (Y
obs=1,D>0)
P (Y obs=0,D>0)
· P (Y
obs=0,D=0)
P (Y obs=1,D=0)
= P (Y
obs=1|D>0)
P (Y obs=0|D>0)
· P (Y
obs=0|D=0)
P (Y obs=1|D=0)
.
(18)
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By substituting Equation (15), R∗ is
R∗ = P (Y
obs=1|D>0)
P (Y nmi=0,Y mi=0|D>0)
· P (Y
nmi=0)
P (Y nmi=1)
= P (Y
obs=1|D>0)
P (Y nmi=1,Y mi=0|D>0)
.
(19)
Then, M̂AFFOR is
M̂AFFOR = pf ·
R∗−1
R∗
= P (D > 0|Y obs = 1) · P (Y
mi=1|D>0)
P (Y obs=1|D>0)
= P (Y
mi=1,D>0)
P (Y obs=1)
= P (Y
mi=1)
P (Y obs=1)
(20)
A.3 Estimation of the dispersion parameter in the negative bi-
nomial distribution
In Section 6, we assume that the measurement error model (M2) has the negative binomial
distribution: Dobs|Dcur ∼ 40×NB(Dcur/40, r) where the mean is Dcur/40 and the disper-
sion parameter is r. The dispersion parameter r is not known, but can be estimated from
the data in O’Meara et al. (2007).
O’Meara et al. (2007) computed the false negative rate by counting numbers of slides
reported as negative from 25 microscopists, and they plotted the false nagative rate on the
mean parasite density in Figure 2. We let y be the number of negative slides and x be the
mean parasite density. We use the data (x, y) to find the maximum likelihood estimate of
the dispersion parameter r; yi is the number of ‘negative’ from the binomial distribution
B(n = 25, pi) where pi is the probability of being falsely negative, and pi is computed from
the negative binomial distribution NB(xi/40, r). The log-likelihood is given as
ℓ ∝
∑n
i=1 yi log(pi) + (25− yi) log(1− pi)
=
∑n
i=1 yi log(f(0; xi/40, r)) + (25− yi) log(1− f(0; xi/40, r))
(21)
where f(x; xi/40, r) is the probability mass function of the negative binomial with the mean
xi/40 and the dispersion parameter r. From the data in O’Meara et al. (2007), the estimate
of r is obtained as 5.83, and we use r = 6 in our paper. The R code for this estimation is
provided online.
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